跳至主要内容
临床试验/EUCTR2014-000966-23-NL
EUCTR2014-000966-23-NL进行中(未招募)1 期

The effects of BCG-vaccination on the immune response induced by influenza-vaccination in healthy volunteers A pilot proof-of-principle study - Effects of BCG on influenza-induced immune response

Radboud University Nijmegen Medical Centre0 个研究点目标入组 72 人开始时间: 2014年4月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • -Age =18 and =35 yrs or =65 yrs
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 32

排除标准

  • -Prior exposure to ‘Influvac’ influenza virus strains , measured by antibody titres. Previous exposure is defined by antibody titres =1:40.
  • -History of influenza vaccination within the year prior to study entry
  • -History of BCG vaccination within 5 years prior to study entry
  • -History of Mantoux testing within the year prior to study entry
  • -Vaccination other than BCG or influenza, within 3 months prior to study or within study period
  • -Medical history of any disease associated with immune deficiency
  • -Clinically significant acute illness, including infections, within 4 weeks before vaccination
  • -Participation in a drug trial or donation of blood 3 months prior to study entry
  • -Use of recreational drugs within 21 days prior to experiment day
  • -Recent hospital admission or surgery with general anaesthesia (<3 months)
  • -Known chronic kidney or liver disease
  • -Latent or active tuberculosis infection

研究者

发起方
Radboud University Nijmegen Medical Centre

相似试验